Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page received minor UI and metadata updates (Show glossary option; updated Last Update Submitted that Met QC Criteria and Last Update Posted fields; No FEAR Act Data labeling; and a new Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check12 days agoNo Change Detected
- Check41 days agoChange DetectedLocation sections were updated with new site listings across the United States and international regions. Previous location sections were removed and the page revision updated to v3.3.3.SummaryDifference2%
- Check63 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, representing a minor site maintenance update that does not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check70 days agoChange DetectedRelated topics Melanoma and MedlinePlus Genetics were added and the publication note was revised. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check77 days agoChange DetectedThe page no longer displays the site-wide funding status notice and removes Melanoma-related topics and MedlinePlus Genetics from the related topics section. These removals do not modify the study's core content, such as eligibility criteria, endpoints, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check91 days agoChange DetectedNew metadata entries were added (Melanoma; MedlinePlus Genetics) and related topic tags, with associated dates updated (2025-09-24, 2025-10-23, 2025-10-27). Several older date markers were removed (2025-10-06, 2025-10-14, 2025-10-16).SummaryDifference0.7%
Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.